Average Co-Inventor Count = 4.17
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Georgetown University (15 from 484 patents)
2. Shuttle Pharmaceuticals, Inc. (9 from 9 patents)
3. University of Illinois (1 from 2,340 patents)
4. Neopharm, Inc. (1 from 6 patents)
24 patents:
1. 12357650 - Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorlylase inhibitors in combination with radiation
2. 12077515 - Selective histone deacetylase inhibitors for the treatment of human disease
3. 11654157 - Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorylase inhibitors in combination with radiation
4. 11584733 - Selective histone deacetylase inhibitors for the treatment of human disease
5. 11407723 - Selective histone deacetylase inhibitors for the treatment of human disease
6. 11034667 - Selective histone deacetylase inhibitors for the treatment of human disease
7. 10745352 - Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof
8. 10730834 - Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof
9. 9809539 - Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof
10. 8748463 - Histone deacetylase inhibitors and methods of use thereof
11. 8653278 - Isoform selective HDAC inhibitors
12. 8293513 - Histone deacetylase inhibitors
13. 8222451 - Histone deacetylase inhibitors and methods of use thereof
14. 7842835 - Histone deacetylase inhibitors and methods of use thereof
15. 7442520 - Gene BRCC-3 and diagnostic and therapeutic uses thereof